We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

FDA Must Act Quickly On Ranbaxy Lipitor ANDA: Mylan

Law360 (April 28, 2011, 6:54 PM EDT) -- Mylan Pharmaceuticals Inc. asked a Washington federal judge on Thursday not to toss its suit seeking to compel the U.S. Food and Drug Administration to remove the exclusivity provision from Ranbaxy...
To view the full article, register now.



Case Information

Case Title

Subscribers Only

Case Number

Subscribers Only


District Of Columbia

Nature of Suit

Other Statutory Actions


Subscribers Only

Date Filed

March 18, 2011

Law Firms


Government Agencies

Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.